Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.
Actively Recruiting
This observational study is a global, patient-powered registry designed to gather detailed information about individuals affected by appendix cancer and Pseudomyxoma Peritonei PMP. The study aims to improve understanding of these rare diseases by tracking their characteristics, clinical course, treatment patterns, and progression over time. It supports research by providing a rich data source to help develop care recommendations and accelerate new treatment discoveries. Participants, caregivers, or authorized representatives contribute data through online surveys, including uploading medical documents such as pathology reports and genomic sequencing results. The registry collects both retrospective and prospective information on demographics, medical history, treatment details, disease progression, and quality of life. Participants are encouraged to update their information periodically to capture changes over time. Throughout the study, researchers assess various outcomes including the natural history of appendix cancer and PMP, disease characteristics, treatment history, diagnosis, disease progression, care management, and signs and symptoms up to five years. The registry is managed by the ACPMP Research Foundation and hosted on the NORD IAMRARE platform under ethical oversight to ensure data protection and appropriate research use. The study runs from February 2026 to February 2030.